Resistin gene polymorphisms and progression of glycaemia in southern Chinese: a 5-year prospective study

Summary Objective  Human resistin gene (RETN) polymorphisms have been found to be associated with type 2 diabetes (T2DM), insulin resistance and/or obesity. We evaluated, in a 5‐year prospective study, whether RETN polymorphisms could predict the progression of glycaemia in southern Chinese. Design...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical endocrinology (Oxford) 2007-02, Vol.66 (2), p.211-217
Hauptverfasser: Xu, Jian Yu, Sham, Pak C., Xu, Aimin, Tso, Annette W. K., Wat, Nelson M. S., Cheng, King Yip, Fong, Carol H. Y., Janus, Edward D., Lam, Karen S. L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 217
container_issue 2
container_start_page 211
container_title Clinical endocrinology (Oxford)
container_volume 66
creator Xu, Jian Yu
Sham, Pak C.
Xu, Aimin
Tso, Annette W. K.
Wat, Nelson M. S.
Cheng, King Yip
Fong, Carol H. Y.
Janus, Edward D.
Lam, Karen S. L.
description Summary Objective  Human resistin gene (RETN) polymorphisms have been found to be associated with type 2 diabetes (T2DM), insulin resistance and/or obesity. We evaluated, in a 5‐year prospective study, whether RETN polymorphisms could predict the progression of glycaemia in southern Chinese. Design and patients  We conducted a systematic search for variants in RETN in 70 southern Chinese subjects. This was followed by the genotyping in 624 unrelated nondiabetic subjects of two polymorphisms, −420C→G and +62G→A, previously reported in cross‐sectional studies to be associated with T2DM in Asians, to examine their relationship with the progression of glycaemia in this cohort. Results  We identified 15 polymorphisms, including 2 novel but rare polymorphisms (−319G→A and +63G→C). Compared to subjects with the CC genotype, −420GG subjects had higher 2‐h glucose (7·7 ± 1·8 vs. 7·2 ± 2·0 mmol/l, P = 0·011) and insulin (101·6 ± 69·5 vs. 79·8 ± 59·5 mU/l, P = 0·021) during an oral glucose tolerance test. Carriers of the +62A allele had higher body mass indices (25·3 ± 4·0 vs. 24·5 ± 3·6 kg/m2 in GG, P = 0·02). The presence of the allele −420G (OR 2·15, 95% CI 1·28–3·60, P = 0·004) or +62A (OR1·86, 95% CI 1·08–3·21, P = 0·025) predicted the progression of glycaemia at Year 5, after adjustment for sex, age or body mass index. The haplotype G‐A also conferred a higher risk of progression in glycaemia (P = 0·002). Conclusion  Our study would support the role of the resistin gene in obesity, insulin resistance and progression of glycaemia in southern Chinese.
doi_str_mv 10.1111/j.1365-2265.2006.02710.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68427446</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68427446</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5010-152ee4cc3c02c1f2dedd557ee44d357a04a271be84a8f2bfd1374e09dc5153ae3</originalsourceid><addsrcrecordid>eNqNkUuP0zAURi0EYsrAX0DewC7l-hWnSCxQNAyIahBoeOws17lpXfIodgLNv8eh1cwWb2z5nmNffyaEMliyNF7tl0zkKuM8V0sOkC-B61Q7PiCLu8JDsgABkEGeywvyJMY9AKgC9GNywTTnYrWCBdl9wejj4Du6xQ7poW-mtg-HnY9tpLar6CH024Ax-r6jfU23zeQstt7SpMR-HHYYOlrufIcRX1NLVTahDbMWD-gG_xtpHMZqekoe1baJ-Ow8X5Kv765uy_fZ-tP1h_LtOnMKGGRMcUTpnHDAHat5hVWllE57shJKW5A2PXWDhbRFzTd1xYSWCKvKKaaERXFJXp7OTR38GjEOpvXRYdPYDvsxmryQXEuZJ7A4gS61GgPW5hB8a8NkGJg5ZbM3c5hmDtPMKZt_KZtjUp-f7xg3LVb34jnWBLw4AzY629TBds7He66QhZb5KnFvTtwf3-D03w2Y8upmXiU_O_npC_F459vw0-RaaGW-31wb_XHNf9x-_mZK8ReBRKkP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68427446</pqid></control><display><type>article</type><title>Resistin gene polymorphisms and progression of glycaemia in southern Chinese: a 5-year prospective study</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Xu, Jian Yu ; Sham, Pak C. ; Xu, Aimin ; Tso, Annette W. K. ; Wat, Nelson M. S. ; Cheng, King Yip ; Fong, Carol H. Y. ; Janus, Edward D. ; Lam, Karen S. L.</creator><creatorcontrib>Xu, Jian Yu ; Sham, Pak C. ; Xu, Aimin ; Tso, Annette W. K. ; Wat, Nelson M. S. ; Cheng, King Yip ; Fong, Carol H. Y. ; Janus, Edward D. ; Lam, Karen S. L.</creatorcontrib><description>Summary Objective  Human resistin gene (RETN) polymorphisms have been found to be associated with type 2 diabetes (T2DM), insulin resistance and/or obesity. We evaluated, in a 5‐year prospective study, whether RETN polymorphisms could predict the progression of glycaemia in southern Chinese. Design and patients  We conducted a systematic search for variants in RETN in 70 southern Chinese subjects. This was followed by the genotyping in 624 unrelated nondiabetic subjects of two polymorphisms, −420C→G and +62G→A, previously reported in cross‐sectional studies to be associated with T2DM in Asians, to examine their relationship with the progression of glycaemia in this cohort. Results  We identified 15 polymorphisms, including 2 novel but rare polymorphisms (−319G→A and +63G→C). Compared to subjects with the CC genotype, −420GG subjects had higher 2‐h glucose (7·7 ± 1·8 vs. 7·2 ± 2·0 mmol/l, P = 0·011) and insulin (101·6 ± 69·5 vs. 79·8 ± 59·5 mU/l, P = 0·021) during an oral glucose tolerance test. Carriers of the +62A allele had higher body mass indices (25·3 ± 4·0 vs. 24·5 ± 3·6 kg/m2 in GG, P = 0·02). The presence of the allele −420G (OR 2·15, 95% CI 1·28–3·60, P = 0·004) or +62A (OR1·86, 95% CI 1·08–3·21, P = 0·025) predicted the progression of glycaemia at Year 5, after adjustment for sex, age or body mass index. The haplotype G‐A also conferred a higher risk of progression in glycaemia (P = 0·002). Conclusion  Our study would support the role of the resistin gene in obesity, insulin resistance and progression of glycaemia in southern Chinese.</description><identifier>ISSN: 0300-0664</identifier><identifier>EISSN: 1365-2265</identifier><identifier>DOI: 10.1111/j.1365-2265.2006.02710.x</identifier><identifier>PMID: 17223990</identifier><identifier>CODEN: CLECAP</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Biological and medical sciences ; China ; Disease Progression ; Endocrinopathies ; Female ; Fundamental and applied biological sciences. Psychology ; Gene Frequency ; Genotype ; Humans ; Hyperglycemia - genetics ; Insulin Resistance - genetics ; Longitudinal Studies ; Male ; Medical sciences ; Middle Aged ; Obesity - genetics ; Polymorphism, Single Nucleotide ; Prospective Studies ; Resistin - genetics ; Vertebrates: endocrinology</subject><ispartof>Clinical endocrinology (Oxford), 2007-02, Vol.66 (2), p.211-217</ispartof><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5010-152ee4cc3c02c1f2dedd557ee44d357a04a271be84a8f2bfd1374e09dc5153ae3</citedby><cites>FETCH-LOGICAL-c5010-152ee4cc3c02c1f2dedd557ee44d357a04a271be84a8f2bfd1374e09dc5153ae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2265.2006.02710.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2265.2006.02710.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18487469$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17223990$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xu, Jian Yu</creatorcontrib><creatorcontrib>Sham, Pak C.</creatorcontrib><creatorcontrib>Xu, Aimin</creatorcontrib><creatorcontrib>Tso, Annette W. K.</creatorcontrib><creatorcontrib>Wat, Nelson M. S.</creatorcontrib><creatorcontrib>Cheng, King Yip</creatorcontrib><creatorcontrib>Fong, Carol H. Y.</creatorcontrib><creatorcontrib>Janus, Edward D.</creatorcontrib><creatorcontrib>Lam, Karen S. L.</creatorcontrib><title>Resistin gene polymorphisms and progression of glycaemia in southern Chinese: a 5-year prospective study</title><title>Clinical endocrinology (Oxford)</title><addtitle>Clin Endocrinol (Oxf)</addtitle><description>Summary Objective  Human resistin gene (RETN) polymorphisms have been found to be associated with type 2 diabetes (T2DM), insulin resistance and/or obesity. We evaluated, in a 5‐year prospective study, whether RETN polymorphisms could predict the progression of glycaemia in southern Chinese. Design and patients  We conducted a systematic search for variants in RETN in 70 southern Chinese subjects. This was followed by the genotyping in 624 unrelated nondiabetic subjects of two polymorphisms, −420C→G and +62G→A, previously reported in cross‐sectional studies to be associated with T2DM in Asians, to examine their relationship with the progression of glycaemia in this cohort. Results  We identified 15 polymorphisms, including 2 novel but rare polymorphisms (−319G→A and +63G→C). Compared to subjects with the CC genotype, −420GG subjects had higher 2‐h glucose (7·7 ± 1·8 vs. 7·2 ± 2·0 mmol/l, P = 0·011) and insulin (101·6 ± 69·5 vs. 79·8 ± 59·5 mU/l, P = 0·021) during an oral glucose tolerance test. Carriers of the +62A allele had higher body mass indices (25·3 ± 4·0 vs. 24·5 ± 3·6 kg/m2 in GG, P = 0·02). The presence of the allele −420G (OR 2·15, 95% CI 1·28–3·60, P = 0·004) or +62A (OR1·86, 95% CI 1·08–3·21, P = 0·025) predicted the progression of glycaemia at Year 5, after adjustment for sex, age or body mass index. The haplotype G‐A also conferred a higher risk of progression in glycaemia (P = 0·002). Conclusion  Our study would support the role of the resistin gene in obesity, insulin resistance and progression of glycaemia in southern Chinese.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>China</subject><subject>Disease Progression</subject><subject>Endocrinopathies</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Frequency</subject><subject>Genotype</subject><subject>Humans</subject><subject>Hyperglycemia - genetics</subject><subject>Insulin Resistance - genetics</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Obesity - genetics</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Prospective Studies</subject><subject>Resistin - genetics</subject><subject>Vertebrates: endocrinology</subject><issn>0300-0664</issn><issn>1365-2265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUuP0zAURi0EYsrAX0DewC7l-hWnSCxQNAyIahBoeOws17lpXfIodgLNv8eh1cwWb2z5nmNffyaEMliyNF7tl0zkKuM8V0sOkC-B61Q7PiCLu8JDsgABkEGeywvyJMY9AKgC9GNywTTnYrWCBdl9wejj4Du6xQ7poW-mtg-HnY9tpLar6CH024Ax-r6jfU23zeQstt7SpMR-HHYYOlrufIcRX1NLVTahDbMWD-gG_xtpHMZqekoe1baJ-Ow8X5Kv765uy_fZ-tP1h_LtOnMKGGRMcUTpnHDAHat5hVWllE57shJKW5A2PXWDhbRFzTd1xYSWCKvKKaaERXFJXp7OTR38GjEOpvXRYdPYDvsxmryQXEuZJ7A4gS61GgPW5hB8a8NkGJg5ZbM3c5hmDtPMKZt_KZtjUp-f7xg3LVb34jnWBLw4AzY629TBds7He66QhZb5KnFvTtwf3-D03w2Y8upmXiU_O_npC_F459vw0-RaaGW-31wb_XHNf9x-_mZK8ReBRKkP</recordid><startdate>200702</startdate><enddate>200702</enddate><creator>Xu, Jian Yu</creator><creator>Sham, Pak C.</creator><creator>Xu, Aimin</creator><creator>Tso, Annette W. K.</creator><creator>Wat, Nelson M. S.</creator><creator>Cheng, King Yip</creator><creator>Fong, Carol H. Y.</creator><creator>Janus, Edward D.</creator><creator>Lam, Karen S. L.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200702</creationdate><title>Resistin gene polymorphisms and progression of glycaemia in southern Chinese: a 5-year prospective study</title><author>Xu, Jian Yu ; Sham, Pak C. ; Xu, Aimin ; Tso, Annette W. K. ; Wat, Nelson M. S. ; Cheng, King Yip ; Fong, Carol H. Y. ; Janus, Edward D. ; Lam, Karen S. L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5010-152ee4cc3c02c1f2dedd557ee44d357a04a271be84a8f2bfd1374e09dc5153ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>China</topic><topic>Disease Progression</topic><topic>Endocrinopathies</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Frequency</topic><topic>Genotype</topic><topic>Humans</topic><topic>Hyperglycemia - genetics</topic><topic>Insulin Resistance - genetics</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Obesity - genetics</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Prospective Studies</topic><topic>Resistin - genetics</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xu, Jian Yu</creatorcontrib><creatorcontrib>Sham, Pak C.</creatorcontrib><creatorcontrib>Xu, Aimin</creatorcontrib><creatorcontrib>Tso, Annette W. K.</creatorcontrib><creatorcontrib>Wat, Nelson M. S.</creatorcontrib><creatorcontrib>Cheng, King Yip</creatorcontrib><creatorcontrib>Fong, Carol H. Y.</creatorcontrib><creatorcontrib>Janus, Edward D.</creatorcontrib><creatorcontrib>Lam, Karen S. L.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical endocrinology (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xu, Jian Yu</au><au>Sham, Pak C.</au><au>Xu, Aimin</au><au>Tso, Annette W. K.</au><au>Wat, Nelson M. S.</au><au>Cheng, King Yip</au><au>Fong, Carol H. Y.</au><au>Janus, Edward D.</au><au>Lam, Karen S. L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Resistin gene polymorphisms and progression of glycaemia in southern Chinese: a 5-year prospective study</atitle><jtitle>Clinical endocrinology (Oxford)</jtitle><addtitle>Clin Endocrinol (Oxf)</addtitle><date>2007-02</date><risdate>2007</risdate><volume>66</volume><issue>2</issue><spage>211</spage><epage>217</epage><pages>211-217</pages><issn>0300-0664</issn><eissn>1365-2265</eissn><coden>CLECAP</coden><abstract>Summary Objective  Human resistin gene (RETN) polymorphisms have been found to be associated with type 2 diabetes (T2DM), insulin resistance and/or obesity. We evaluated, in a 5‐year prospective study, whether RETN polymorphisms could predict the progression of glycaemia in southern Chinese. Design and patients  We conducted a systematic search for variants in RETN in 70 southern Chinese subjects. This was followed by the genotyping in 624 unrelated nondiabetic subjects of two polymorphisms, −420C→G and +62G→A, previously reported in cross‐sectional studies to be associated with T2DM in Asians, to examine their relationship with the progression of glycaemia in this cohort. Results  We identified 15 polymorphisms, including 2 novel but rare polymorphisms (−319G→A and +63G→C). Compared to subjects with the CC genotype, −420GG subjects had higher 2‐h glucose (7·7 ± 1·8 vs. 7·2 ± 2·0 mmol/l, P = 0·011) and insulin (101·6 ± 69·5 vs. 79·8 ± 59·5 mU/l, P = 0·021) during an oral glucose tolerance test. Carriers of the +62A allele had higher body mass indices (25·3 ± 4·0 vs. 24·5 ± 3·6 kg/m2 in GG, P = 0·02). The presence of the allele −420G (OR 2·15, 95% CI 1·28–3·60, P = 0·004) or +62A (OR1·86, 95% CI 1·08–3·21, P = 0·025) predicted the progression of glycaemia at Year 5, after adjustment for sex, age or body mass index. The haplotype G‐A also conferred a higher risk of progression in glycaemia (P = 0·002). Conclusion  Our study would support the role of the resistin gene in obesity, insulin resistance and progression of glycaemia in southern Chinese.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>17223990</pmid><doi>10.1111/j.1365-2265.2006.02710.x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0300-0664
ispartof Clinical endocrinology (Oxford), 2007-02, Vol.66 (2), p.211-217
issn 0300-0664
1365-2265
language eng
recordid cdi_proquest_miscellaneous_68427446
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adult
Biological and medical sciences
China
Disease Progression
Endocrinopathies
Female
Fundamental and applied biological sciences. Psychology
Gene Frequency
Genotype
Humans
Hyperglycemia - genetics
Insulin Resistance - genetics
Longitudinal Studies
Male
Medical sciences
Middle Aged
Obesity - genetics
Polymorphism, Single Nucleotide
Prospective Studies
Resistin - genetics
Vertebrates: endocrinology
title Resistin gene polymorphisms and progression of glycaemia in southern Chinese: a 5-year prospective study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T00%3A58%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Resistin%20gene%20polymorphisms%20and%20progression%20of%20glycaemia%20in%20southern%20Chinese:%20a%205-year%20prospective%20study&rft.jtitle=Clinical%20endocrinology%20(Oxford)&rft.au=Xu,%20Jian%20Yu&rft.date=2007-02&rft.volume=66&rft.issue=2&rft.spage=211&rft.epage=217&rft.pages=211-217&rft.issn=0300-0664&rft.eissn=1365-2265&rft.coden=CLECAP&rft_id=info:doi/10.1111/j.1365-2265.2006.02710.x&rft_dat=%3Cproquest_cross%3E68427446%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68427446&rft_id=info:pmid/17223990&rfr_iscdi=true